Date published: 2025-10-25

1-800-457-3801

SCBT Portrait Logo
Seach Input

RanBPM Inhibitors

RanBPM inhibitors are a class of chemical compounds specifically designed to target and inhibit the function of RanBPM (Ran-binding protein in the microtubule-organizing center), a multifunctional scaffold protein involved in several cellular processes, including signal transduction, cytoskeletal organization, and transcriptional regulation. RanBPM interacts with a variety of proteins through its multiple domains, including its SPRY domain, which mediates protein-protein interactions, and its LisH domain, involved in dimerization and cytoskeletal dynamics. As a scaffold protein, RanBPM plays a critical role in assembling protein complexes that regulate processes such as cell migration, apoptosis, and transcriptional control. Inhibitors of RanBPM act by binding to these critical domains, thereby disrupting its ability to mediate protein-protein interactions and impairing the downstream signaling pathways that rely on RanBPM scaffolding functions.

Inhibition of RanBPM leads to disruptions in the cellular processes it regulates, particularly those involving cytoskeletal integrity, intracellular trafficking, and signal transduction. By blocking RanBPM's interactions with key proteins, these inhibitors prevent the assembly of essential multiprotein complexes, thereby affecting cellular functions such as cell adhesion, migration, and response to external stimuli. Researchers use RanBPM inhibitors to explore the protein's role in various signaling pathways, as well as to investigate how it contributes to the organization of protein complexes within cells. These inhibitors provide valuable insights into the molecular mechanisms by which RanBPM influences diverse cellular processes, offering a clearer understanding of how scaffold proteins contribute to maintaining cellular architecture and transmitting signals from the cell surface to the nucleus. Additionally, RanBPM inhibitors help to elucidate the protein's broader role in coordinating signaling networks and its involvement in processes that regulate cellular behavior and structural organization.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

5-Azacytidine

320-67-2sc-221003
500 mg
$280.00
4
(1)

May lead to the demethylation of CpG islands within the RanBPM promoter, potentially resulting in the transcriptional silencing of the gene.

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$149.00
$470.00
$620.00
$1199.00
$2090.00
33
(3)

Could enhance histone acetylation, thereby altering the accessibility of transcriptional machinery to the RanBPM gene and leading to decreased expression.

Actinomycin D

50-76-0sc-200906
sc-200906A
sc-200906B
sc-200906C
sc-200906D
5 mg
25 mg
100 mg
1 g
10 g
$73.00
$238.00
$717.00
$2522.00
$21420.00
53
(3)

May directly bind to DNA and obstruct the elongation phase of RNA polymerase during RanBPM gene transcription, leading to a reduction in mRNA synthesis.

Doxorubicin

23214-92-8sc-280681
sc-280681A
1 mg
5 mg
$173.00
$418.00
43
(3)

By stabilizing the DNA-topoisomerase II complex, it could interfere with the transcriptional machinery's ability to properly transcribe the RanBPM gene.

Mithramycin A

18378-89-7sc-200909
1 mg
$54.00
6
(1)

Might selectively bind to the RanBPM gene promoter's GC-rich sequences, obstructing the necessary transcription factors and leading to decreased gene expression.

Chloroquine

54-05-7sc-507304
250 mg
$68.00
2
(0)

Could disrupt lysosomal degradation pathways, leading to the accumulation of transcriptional repressors that specifically target and downregulate RanBPM expression.

(±)-JQ1

1268524-69-1sc-472932
sc-472932A
5 mg
25 mg
$226.00
$846.00
1
(0)

Could competitively inhibit BET bromodomains, leading to the displacement of transcriptional regulators from chromatin and subsequent downregulation of RanBPM transcription.

5-Aza-2′-Deoxycytidine

2353-33-5sc-202424
sc-202424A
sc-202424B
25 mg
100 mg
250 mg
$214.00
$316.00
$418.00
7
(1)

Could induce DNA hypomethylation and promote the binding of repressive transcription factors to the RanBPM promoter, culminating in decreased gene expression.

Suberoylanilide Hydroxamic Acid

149647-78-9sc-220139
sc-220139A
100 mg
500 mg
$130.00
$270.00
37
(2)

This HDAC inhibitor could lead to hyperacetylation of histones associated with the RanBPM gene, resulting in the recruitment of transcriptional co-repressors and diminished expression.

Tamoxifen

10540-29-1sc-208414
2.5 g
$256.00
18
(2)

Could interfere with estrogen receptor-mediated transcriptional activation of the RanBPM gene, leading to a reduction in its expression levels in certain breast tissue cells.